Divi's Laboratories: A Deep Dive into the Pharma Titan's CDMO Moat
This article explores the competitive landscape of Divi's Laboratories, highlighting its strength in complex chemical synthesis and the CDMO business segment. It provides a structural analysis of the company's financial model, risk factors, and its strategic position within the global 'China Plus One' supply chain shift.